LivaNova Stock Quote LIVN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

45.76

Bid

45.39

Ask

51.15

Volume

417,134

45.63 Day's Range 46.47

32.48 52 Week Range 57.29

Market Cap

2.495B

Previous Close

46.63

Open

46.05

Last Trade

5836

45.76

(priorref)

Last Trade Time

Financial Volume

$ 19,190,507

VWAP

46.0056

Average Volume (3m)

800,185

Shares Outstanding

54,525,691

Dividend Yield

PE Ratio

39.45

Earnings Per Share (EPS)

1.16

Revenue

1.25B

Net Profit

63.23M

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare prof... LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare professionals and healthcare systems. At LivaNova we understand the importance of bringing both clinical and economic value to our customers. We are a strong market-leading medical technology and services company offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol LIVN. LivaNova has approximately 3000 employees worldwide. We are headquartered in London UK and maintain a presence in more than 100 countries. LivaNova is a worldwide leader in advanced circulatory support cardiopulmonary and neuromodulation dedicated to creating meaningful products and therapies that transform lives each and every day. Show more

Sector

Electromedical Apparatus

Industry

Electromedical Apparatus

Website

www.livanova.com

Headquarters

London, Gbr

Founded

LivaNova PLC is listed in the Electromedical Apparatus sector of the NASDAQ with ticker LIVN. The last closing price for LivaNova was $46.63. Over the last year, LivaNova shares have traded in a share price range of $ 32.48 to $ 57.29.

LivaNova currently has 54,525,691 shares outstanding. The market capitalization of LivaNova is $2.54 billion. LivaNova has a price to earnings ratio (PE ratio) of 39.45.

Form 8-K - Current report

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (Nasdaq:...

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy

This is the latest prospective evaluation of VNS Therapy in generalized tonic-clonic seizures Findings include 77% median seizure reduction and...

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Final critical papers on RECOVER clinical study data accepted, supporting the Company’s submission for coverage reconsideration Strong 24-month...

Form SD - Specialized disclosure report

LivaNova to Present at the Jefferies Global Healthcare Conference

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will...

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.54	1.19416187528	45.22	47.88	45.11	772572	46.58677674	CS
4	1.9	4.33196534428	43.86	47.88	41.725	650015	44.6184557	CS
12	5.735	14.3285446596	40.025	47.88	32.48	800185	40.17146048	CS
26	-6.09	-11.7454194793	51.85	52.28	32.48	707689	42.28425834	CS
52	-6.59	-12.58834766	52.35	57.29	32.48	641664	46.1979052	CS
156	-18.17	-28.4217112467	63.93	66.73	32.48	544372	50.0441124	CS
260	-0.58	-1.25161847216	46.34	93.89	32.48	495465	56.52673678	CS

LIVN - Frequently Asked Questions (FAQ)

What is the current LivaNova share price?

The current share price of LivaNova is $ 45.76

How many LivaNova shares are in issue?

LivaNova has 54,525,691 shares in issue

What is the market cap of LivaNova?

The market capitalisation of LivaNova is USD 2.54B

What is the 1 year trading range for LivaNova share price?

LivaNova has traded in the range of $ 32.48 to $ 57.29 during the past year

What is the PE ratio of LivaNova?

The price to earnings ratio of LivaNova is 39.45

What is the cash to sales ratio of LivaNova?

The cash to sales ratio of LivaNova is 1.99

What is the reporting currency for LivaNova?

LivaNova reports financial results in USD

What is the latest annual turnover for LivaNova?

The latest annual turnover of LivaNova is USD 1.25B

What is the latest annual profit for LivaNova?

The latest annual profit of LivaNova is USD 63.23M

What is the registered address of LivaNova?

The registered address for LivaNova is 20 EASTBOURNE TERRACE, NORTH WHARF ROAD, LONDON, W2 6LG

What is the LivaNova website address?

The website address for LivaNova is www.livanova.com

Which industry sector does LivaNova operate in?

LivaNova operates in the ELECTROMEDICAL APPARATUS sector

Symbol	Price	Vol.
RBNERobin Energy Ltd	$ 13.85 (313.43%)	101.81M
OPOceanPal Inc	$ 1.63 (125.45%)	80.28M
LGHLWLion Group Holding Ltd	$ 0.0052 (116.67%)	6.87M
NEONNeonode Inc	$ 16.83 (68.47%)	4.78M
ICONIcon Energy Corporation	$ 2.90 (62.01%)	59.04M
SBETSharpLink Gaming Inc	$ 9.2275 (-71.63%)	41.92M
AIHSSenmiao Technology Ltd	$ 0.381 (-63.01%)	16.8M
CHSNChanson International Holding	$ 0.22 (-60.00%)	15.15M
KWMK Wave Media Ltd	$ 2.91 (-50.43%)	2.59M
JZXNJiuzi Holdings Inc	$ 1.56 (-46.39%)	2.24M
HCTIHealthcare Triangle Inc	$ 0.0201 (-33.00%)	856.89M
GNLNGreenlane Holdings Inc	$ 0.0101 (-34.42%)	792.34M
CGBSCrown LNG Holdings Ltd	$ 0.1104 (31.43%)	788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.655 (3.81%)	246.13M
NVDANVIDIA Corporation	$ 141.97 (-2.09%)	180.81M

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

LivaNova PLC (LIVN) Quote

LivaNova PLC (LIVN)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About LivaNova PLC

Ask ADVFN Intelligence (AI)

LIVN Latest News

Form 8-K - Current report

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Form SD - Specialized disclosure report

LivaNova to Present at the Jefferies Global Healthcare Conference

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

Form 8-K - Current report

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Form SD - Specialized disclosure report

LivaNova to Present at the Jefferies Global Healthcare Conference

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Form ARS - Annual Report to Security Holders

LIVN - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Sign in

Go Ad-Free